References

1. King DR, Ramly EP. Resuscitation of the trauma patient. In:Cohn SM, Dolich MD, Inaba K, eds. Acute Care Surgery and Trauma. 2nd ed. Boca Raton, FL: CRC Press; 2016:71-78.
2. Callum J, Yeh CH, Petrosoniak A, et al. A regional massive hemorrhage protocol developed through a modified Delphi technique. CMAJ Open. 2019;7(3):E546-E561.
3. Meyer DE, Vincent LE, Fox EE, et al. Every minute counts: time to delivery of initial massive transfusion cooler and its impact on mortality. J Trauma Acute Care Surg. 2017;83(1):19-24.
4. Jennings LK, Watson S. Massive transfusion. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2021.
5. Vandromme MJ, Griffin RL, Kerby JD, et al. Identifying risk for massive transfusion in the relatively normotensive patient: utility of the prehospital shock index. J Trauma. 2011;70(2):384-388; discussion: 388-390.
6. Hanna K, Harris C, Trust MD, et al. Multicenter validation of the revised assessment of bleeding and transfusion (RABT) score for predicting massive transfusion. World J Surg. 2020;44(6):1807-1816.
7. Meyer DE, Cotton BA, Fox EE, et al. A comparison of resuscitation intensity and critical administration threshold in predicting early mortality among bleeding patients: a multicenter validation in 680 major transfusion patients. J Trauma Acute Care Surg. 2018;85(4):691-696.
8. Holcomb JB, Tilley BC, Baraniuk S, et al. Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma. JAMA. 2015;313(5):471-482.
9. Levy JH, Welsby I, Goodnough LT. Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. Transfusion. 2014;54(5):1389-1405.
10. Hicks C, Petrosoniak A. The human factor: optimizing trauma team performance in dynamic clinical environments. Emerg Med Clin North Am. 2018;36(1):1-17.
11. Simmons JW, Pittet JF, Pierce B. Trauma-induced coagulopathy. Curr Anesthesiol Rep. 2014;4(3):189-199.
12. Sahin AS, Ozkan S. Treatment of obstetric hemorrhage with fibrinogen concentrate. Med Sci Monit. 2019;25:1814-1821.
13. Verma A, Kole T. International normalized ratio as a predictor of mortality in trauma patients in India. World J Emerg Med. 2014;5(3):192-195.
14. Brenner A, Afolabi A, Ahmad SM, et al. Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial. 2019;20(1):467.
15. CRASH-2 trial collaborators, Shakur H, Roberts I, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.
16. Gayet-Ageron A, Prieto-Merino D, Ker K, et al. Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. Lancet. 2018;391(10116):125-132.
17. CRASH-3 trial collaborators. Effects of tranexamic acid on death, disability, vascular occlusive events and other morbidities in patients with acute traumatic brain injury (CRASH-3): a randomised, placebo-controlled trial. Lancet. 2019;394(10210):1713-1723.
18. Helman A, Callum J, Haas B, et al. The 7 Ts of massive hemorrhage protocols. Emergency Medicine Cases website. Available at: https://emergencymedicinecases.com/7-ts-massive-hemorrhage-protocols. Accessed March 10, 2021.
19. Kander T, Schött U. Effect of hypothermia on haemostasis and bleeding risk: a narrative review. J Int Med Res. 2019;47(8):3559-3568.